General Information
Revision date
2020-01-15
Product name
ROCEPHIN Powder Vials 2 g
CAS No.
104376-79-6
1.2.1 Relevant identified uses
Pharmaceutical active substance
Emergency telephone
+41-61/688 54 80
Icons in SDS
Company Information
company name
F. Hoffmann-La Roche Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334, H400, H410
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
CLP CLASSIFICATION
Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Short-term (acute) aquatic hazard, Cate- H400: Very toxic to aquatic life. gory 1 Long-term (chronic) aquatic hazard, Cat- H410: Very toxic to aquatic life with long lasting egory 1 effects.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H410 Very toxic to aquatic life with long lasting effects.
Prevention
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P273 Avoid release to the environment. P280 Wear protective gloves.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor. P391 Collect spillage.
Hazardous Ingredients
104376-79-6 Ceftriaxone disodium salt sterile
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
